| The toxicology of heparin reversal with protamine: past, present and future E Sokolowska, B Kalaska, J Miklosz, A Mogielnicki Expert opinion on drug metabolism & toxicology 12 (8), 897-909, 2016 | 131 | 2016 |
| Neurobehavioral effects of uremic toxin–indoxyl sulfate in the rat model M Karbowska, JM Hermanowicz, A Tankiewicz-Kwedlo, B Kalaska, ... Scientific reports 10 (1), 9483, 2020 | 54 | 2020 |
| Kynurenine pathway in chronic kidney disease: what’s old, what’s new, and what’s next? A Mor, B Kalaska, D Pawlak International Journal of Tryptophan Research 13, 1178646920954882, 2020 | 49 | 2020 |
| Antithrombotic effects of pyridinium compounds formed from trigonelline upon coffee roasting B Kalaska, L Piotrowski, A Leszczynska, B Michalowski, K Kramkowski, ... Journal of agricultural and food chemistry 62 (13), 2853-2860, 2014 | 47 | 2014 |
| Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis B Kalaska, E Sokolowska, K Kaminski, K Szczubialka, K Kramkowski, ... European journal of pharmacology 686 (1-3), 81-89, 2012 | 39 | 2012 |
| Elevated levels of peripheral kynurenine decrease bone strength in rats with chronic kidney disease B Kalaska, K Pawlak, T Domaniewski, E Oksztulska-Kolanek, B Znorko, ... Frontiers in physiology 8, 836, 2017 | 38 | 2017 |
| Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin B Kalaska, K Kaminski, E Sokolowska, D Czaplicki, M Kujdowicz, ... PloS one 10 (3), e0119486, 2015 | 36 | 2015 |
| Heparin-binding copolymer reverses effects of unfractionated heparin, enoxaparin, and fondaparinux in rats and mice B Kalaska, K Kaminski, J Miklosz, S Yusa, E Sokolowska, A Blazejczyk, ... Translational Research 177, 98-112. e10, 2016 | 29 | 2016 |
| The toxicokinetic profile of Dex40-GTMAC3—a novel polysaccharide candidate for reversal of unfractionated heparin E Sokolowska, B Kalaska, K Kaminski, A Lewandowska, A Blazejczyk, ... Frontiers in Pharmacology 7, 60, 2016 | 23 | 2016 |
| Oxidized glycerophosphatidylcholines in diabetes through non-targeted metabolomics: their annotation and biological meaning J Godzien, B Kalaska, E Adamska-Patruno, J Siroka, M Ciborowski, ... Journal of Chromatography B 1120, 62-70, 2019 | 22 | 2019 |
| Pharmacogenetic considerations of anticoagulant medication J Miklosz, B Kalaska, A Mogielnicki J Physiol Pharmacol 69 (4), 2018 | 17 | 2018 |
| Anticoagulant properties of poly (sodium 2-(acrylamido)-2-methylpropanesulfonate)-based di-and triblock polymers B Kalaska, K Kaminski, J Miklosz, K Nakai, SI Yusa, D Pawlak, ... Biomacromolecules 19 (7), 3104-3118, 2018 | 17 | 2018 |
| New arginine substituted derivative of poly (allylamine hydrochloride) for heparin reversal K Kamiński, B Kałaska, P Koczurkiewicz, M Michalik, K Szczubiałka, ... MedChemComm 5 (4), 489-495, 2014 | 17 | 2014 |
| The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target B Kalaska, J Miklosz, K Kamiński, B Musielak, SI Yusa, D Pawlak, ... RSC advances 9 (6), 3020-3029, 2019 | 12 | 2019 |
| LP533401 restores bone health in 5/6 nephrectomized rats by a decrease of gut-derived serotonin and regulation of serum phosphate through the inhibition of phosphate co … D Pawlak, B Znorko, B Kalaska, T Domaniewski, R Zawadzki, P Lipowicz, ... Bone 113, 124-136, 2018 | 12 | 2018 |
| Heparin-binding copolymer as a complete antidote for low-molecular-weight heparins in rats B Kalaska, J Miklosz, K Kamiński, J Swieton, A Jakimczuk, SI Yusa, ... Journal of Pharmacology and Experimental Therapeutics 373 (1), 51-61, 2020 | 10 | 2020 |
| Modulation of the paracrine kynurenic system in bone as a new regulator of osteoblastogenesis and bone mineral status in an animal model of chronic kidney disease treated with … A Mor, K Pawlak, B Kalaska, T Domaniewski, B Sieklucka, M Zieminska, ... International Journal of Molecular Sciences 21 (17), 5979, 2020 | 9 | 2020 |
| A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease B Kalaska, K Pawlak, E Oksztulska-Kolanek, T Domaniewski, B Znorko, ... PeerJ 5, e3199, 2017 | 8 | 2017 |
| Cardiovascular and respiratory toxicity of protamine sulfate in zebrafish and rodent models J Miklosz, B Kalaska, P Podlasz, M Chmielewska-Krzesińska, ... Pharmaceutics 13 (3), 359, 2021 | 7 | 2021 |
| The inhibitory effect of protamine on platelets is attenuated by heparin without inducing thrombocytopenia in rodents J Miklosz, B Kalaska, K Kaminski, M Rusak, K Szczubialka, ... Marine drugs 17 (9), 539, 2019 | 7 | 2019 |
Joanna GodzieńAssistant professor, Medical University of Bialystok在 umb.edu.pl 的电子邮件经过验证
Joanna GodzieńAssistant professor, Medical University of Bialystok在 umb.edu.pl 的电子邮件经过验证